Table 1.
Clinical characteristics.
| characteristics | Number | % |
|---|---|---|
| age | ||
| <55 | 117 | 31.45 |
| >=55 | 255 | 68.55 |
| not appplicable | 1 | 0.00 |
| gender | ||
| FEMALE | 121 | 32.44 |
| MALE | 252 | 67.56 |
| Histological_type | ||
| Fibrolamellar_Carcinoma | 3 | 0.8 |
| Hepatocellular_Carcinoma | 363 | 97.32 |
| Hepatocholangiocarcinoma | 7 | 1.88 |
| Histologic_grade | ||
| Grade_1 | 55 | 14.75 |
| Grade_2 | 178 | 47.72 |
| Grade_3 | 123 | 32.98 |
| Grade_4 | 12 | 3.22 |
| not appplicable | 5 | 1.34 |
| clinical_stage | ||
| stage_I | 172 | 46.11 |
| stage_II | 87 | 23.32 |
| stage_III | 85 | 22.79 |
| stage_IV | 5 | 1.34 |
| not appplicable | 24 | 6.43 |
| T_classification | ||
| T1 | 182 | 48.79 |
| T2 | 95 | 25.47 |
| T3 | 80 | 21.45 |
| T4 | 13 | 3.49 |
| Tx | 1 | 0.27 |
| not appplicable | 2 | 0.54 |
| N_classification | ||
| N0 | 253 | 67.83 |
| N1 | 4 | 1.07 |
| Nx | 115 | 30.83 |
| not appplicable | 1 | 0.27 |
| M_classification | ||
| M0 | 267 | 71.58 |
| M1 | 4 | 1.07 |
| Mx | 102 | 27.35 |
| Radiation_therapy | ||
| NO | 340 | 91.15 |
| YES | 8 | 2.14 |
| not appplicable | 25 | 6.7 |
| Residual_tumor | ||
| R0 | 326 | 87.4 |
| R1 | 17 | 4.56 |
| R2 | 1 | 0.27 |
| Rx | 22 | 5.9 |
| not appplicable | 7 | 1.88 |
| survival_status | ||
| DECEASED | 130 | 34.85 |
| LIVING | 243 | 65.15 |
| relapse | ||
| NO | 179 | 55.94 |
| YES | 141 | 44.06 |
| MAST2 | ||
| high | 110 | 29.49 |
| low | 263 | 70.51 |